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Abstract 
 
Serologic assays are commonly used for screening (ELISA) and for confirmation (Western blot) of HIV-1 infection; 
however, both assays have potentially yielded the false-positive or false-negative results. In this study, a diagnostic RT-
PCR assay as an alternative test for detection of HIV-1 was developed. Forty-six plasma specimens from highly risky 
groups, who visited a voluntary counseling and testing for HIV (VCT) in Sanglah Clinic of General Hospital, Denpasar, 
Bali, were tested by RT-PCR assay with specific primers for Pol region of HIV-1 genome. The results of the RT-PCR 
tests were then compared with those of serologic tests to obtain the sensitivity and specificity of RT-PCR assay. The 
results of this study showed that the RT-PCR assay could detect 17 (sensitivity: 65.4%) of 26 serologically positive 
specimens and was unexpectedly able to detect 2 (specificity: 90%) of 20 serologically negative specimens. Thus, the 
RT-PCR assay developed in this study is potential to be used as an alternative test, even though there are numerous 
aspects, particularly the sensitivity, that need to be improved in further research. 
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Introduction 
 
Since Acquired Immunodeficiency Syndrome (AIDS) 
disease was known, it has been the most important 
concern to public health around the world.1, 2 Based on 
UNAIDS data, it was globally reported that by the end 
of 2007 there were 33.2 million HIV-1 infection cases, 
and every day more than 5.700 people died from 
AIDS. 3 In Indonesia, the HIV epidemic is among the 
fastest growing in Asia in that HIV infections occur 
through the use of contaminated injecting equipment, 
unprotected paid sex and, to a lesser extent, unprotected 
sexual activities between men.4 Bali is one of provinces 
in Indonesia with high HIV epidemic.5 
 
Enzyme-linked immunoassay (ELISA) is commonly 
used for screening HIV-1 infection, whereas Western 
blot assay (WB) is only used for confirmation of HIV-1 
infection. Both ELISA and WB assays detect the HIV 
antigens or the HIV specific antibodies. The inferior of 
such both assays always is concerning false-positive or 
false-negative results.6 The false positive is the result of 
unspecific binding of the HIV specific antibodies to non-
HIV proteins, or vice versa. While the false negative can 
be caused by: 1) infected individuals fail to produce 
HIV-1 specific antibodies7; 2) in cases of infection with 
the most divergent HIV-1 strains8; 3) at early phase of 
infection when HIV-1 specific antibody is not produced 
yet9; and 4) seronegativity or immunological dysfunction 
caused by the aggressive disease course. WB is 
especially not often performed because it is more 
expensive.6  
 
Reverse transcription-polymerase chain reaction (RT-
PCR) is a known technique to amplify particular RNA 
directly. This technique is more suitable because it is 
able to detect HIV RNA in the early phase of infection 
even when HIV-1 specific antibody of a newly HIV-1 
infected person is not produced yet, or in the late phase 
in which antibody is unable to be detected.9 Therefore, in 
this study a diagnostic RT-PCR was applied to amplify 
RNA of HIV-1 genome using primer specific to Pol 
region of HIV-1 genome. It was expected that this assay 
could be used as an alternative test for detection of HIV-
1 infection and as part of efforts to reduce transmission 
of HIV-1 especially in Indonesia. 
 
Methods 
 
Forty-six blood specimens, from high-risk patients 
(intravenous drug users, female sex workers, 
widespread sexual risk behaviors, homosexuals, 
recipients of blood transfusion, and babies with HIV-1 
positive mothers), were collected from July to August 
2005 at VCT of RSUP Sanglah, Bali. Blood specimens 
were collected into a vacutainer without EDTA for 
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serologic assay and into a vacutainer with EDTA for 
RT-PCR assay. For serologic assay, specimens were 
tested in VCT of Clinic Sanglah General Hospital-Bali 
by three different rapid test kits i.e. DetermineTM HIV ½ 
(Abbott), ImmunoComb® HIV 1&2 BiSpot (Orgenics), 
and Serodia® HIV ½ (Fujirebio Inc.). HIV-1 positive 
was defined as serum reactive against two or three rapid 
test kits.   
 
HIV-1 RNA(s) were extracted and purified by QIAamp 
Viral RNA Mini Kit (Qiagen®) according to the 
manufacturer’s instruction. One-tube RT-PCR reactions 
were performed by using OneStep RT-PCR Kit 
(Qiagen®) with the following compositions: 1x OneStep 
RT-PCR Buffer, 2.5 mM MgCl2, 1x Q solution, 400 µM 
each of dGTP, dCTP, dTTP and dATP, 0.6 µM each of 
forward (5’-CCC TCA GGT CAC TCT TTG G-3’ and 
5’-CCC TCA AAT CAC YYT TTG G-3’) and reverse 
primers (5’-ATT CCC CCT ATC ATT TTT GG-3’ and 
5’-ATT CCC CCT ATC ATY YTT GG-3’), OneStep 
RT-PCR enzyme mix, 4 µL viral RNA, and added 
nuclease-free water until final volume of 10 µL. Thermal 
cycler, AB Applied Bosystems Gene Amp PCR System, 
was used with cycles: reverse transcription for 30 min at 
50 0C; initial PCR activation step for 15 min at 95 0C; 40 
cycles of denaturing for 30 sec at 94 0C, annealing for 30 
sec at 56 0C, and extension for 30 sec at 72 0C; and final 
extension for 7 min at 72 0C. RT-PCR products were 
analyzed on 8% polyacrylamide gel and visualized on 
ultraviolet light.  
 
The results of RT-PCR tests were compared with those 
of serological tests to obtain the sensitivity and 
specificity of RT-PCR assay.  
 
Results and Discussion 
 
A positive RT-PCR assay was defined by a 150 bp DNA 
fragment visualized at the right position on 
polyacrilamide gel (Figure 1). Optimization of annealing 
temperature (AT) for PCR reaction was performed by 
using pNL43 as template. This result showed that the 
primers could amplify DNA at 57,9 0C, 56,1 0C, 54,8 0C, 
and 54 0C with optimal amplification at 56,1 0C (data not 
shown).  
 
In this study, the RT-PCR assay could detect 17 of 26 
serologically positive specimens (sensitivity: 65.4%). Of 
20 serologically negative specimens, the RT-PCR assay 
showed 18 negative (specificity: 90.0%) and 2 positive 
results (false positive: 10.0%) (Table 1). The results 
disagree with what was reported by Hecht et al. 10 in that 
their RT-PCR assays were able to detect primary HIV 
infection with 100 percent of sensitivity. The different 
results could be due to the strategic differences of RT-
PCR techniques especially the type of used primer, and 
stage of HIV-1 infection when blood is collected. In 
addition, a particular stage of HIV-1 infection also 
influences sensitivity of RT-PCR assay. As having been 
reportedm viremia peak of HIV-1 infection commonly 
occurs at the beginning stage before serologic conversion 
or AIDS.11 In this study, we used plasma obtained from 
the HIV-1 infected patients with clinically variable 
symptoms; it is thought that the stage of HIV-1 infection 
could influence sensitivity and specificity of our 
technique. This thought might explain why RT-PCR 
technique reported by Hecht et al.10 gave 100 percent of 
sensitivity, possibly because of only diagnosing the HIV 
patients with primary infection. Thus, we propose that 
the stage of HIV-1 infection must be considered when 
evaluating a diagnostic RT-PCR.  
 
Moreover, RT-PCR assay was unexpectedly able to 
detect 2 of 20 serologically negative specimens (Table 
1). The results might depict a real true-positive test 
particularly in patients without seroconversion yet at the 
initial infection or having an immunological system 
which failed to stimulate the antibody production at the 
AIDS stage.12 In those conditions, the rapid assay is not 
able to diagnose the patients. These reasons may explain 
why the commercially rapid tests e.g., ImmunoComb® 
HIV 1&2 BiSpot and Serodia® HIV ½ (Fujirebio Inc.) 
could yield false negative tests. 12,13 
 
While the sensitivity and specificity value obtained by 
comparing RT-PCR assay with serological assay, the 
validity of this developing RT-PCR mostly depended on 
how much the sensitivity and specificity of serologic 
assay as a confirmation assay was. It was previously 
reported    that   commercially    rapid    tests    such    as  
 
 
Figure 1.  Results of RT-PCR Assays. M: DNA Ladder. 
Line 1-7: Seven Examples of Tested Samples. 
Line 2-4: Positive Samples. Line 1,5-7: Negative 
Samples. k-: Negative Control. k+: Positive 
Control. bp: Base Pair 
 
 
Tabel 1. Result of RT-PCR Assay Compared with Serologic 
Assay 
Serology 
 Reactive Non Reactive Total 
Positive 17   2 19 
Negative   9 18 27 RT-PCR
Total 26 20 46 
72 
118 
194 
bp M     k+     1     2      3     4      5      6      7      k- 
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ImmunoComb® HIV 1 & 2 BiSpot, Serodia® HIV ½ 
(Fujirebio Inc.), and DetermineTM  HIV ½ (Abbott)  were  
also able to yield false positive tests.12-14 This 
disadvantage might be one of many factors leading the 
sensitivity of our assay to be low. This assumption has to 
be confirmed by a technique like real time RT-PCR that 
is much more sensitive and specific.  
 
Conclusion 
 
Even though the sensitivity (65.4%) of diagnostic RT-
PCR assay developed in this study was low, use of 
molecular method for detection of HIV-1 seems justified 
in a diagnostic approach. Molecular diagnosis defined in 
this study has a major advantage: it is simple to carry out 
with high specificity, even though there are numerous 
aspects, e.g. type of primer and its target, that need to be 
optimized in order the sensitivity to be improved. 
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